RABL6A promotes pancreatic neuroendocrine tumor angiogenesis and progression in vivo
C. K. Maharjan, C. A. Kaemmer, V. P. Muniz, C. Bauchle, S. L. Mott, K. D. Zamba, P. Breheny, M. R. Leidinger, B. W. Darbro, S. Stephens, D. K. Meyerholz, D. E. Quelle
This study shows RABL6A promotes pancreatic neuroendocrine tumor angiogenesis and progression in vivo by affecting tumor formation, angiogenesis, and survival.
bioRxiv · Mar 17, 2021Cancer Biology